Biogen Pharmachem Industries L / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €81.62K -47.8% -€28.50K -115.2% -34.9% -1.6 pp -€106.21K -156.1% -130.1% -2.5 pp
    €156.37K +141.2% €187.96K +323.9% 120.2% +0.52 pp €189.32K +14.1% 121.1% -1.3 pp
    €64.82K -69.2% €44.35K -5,400.5% 68.4% +0.69 pp €165.94K +21.9% 256.0% +1.9 pp
    €210.47K +14,841.4% -€836.63 -99.5% -0.4% +110 pp €136.14K -64.6% 64.7% -270 pp
    €1.41K -5,887.7% -€156.08K +1,273.8% -11,080.2% -580 pp €384.54K -425.8% 27,298.9% -4.6K pp
    -€24.34 -100.0% -€11.36K +3,189.3% 46,678.7% +470 pp -€118.01K -1,485.2% 484,884.2% +4.8K pp
    €92.48K -114.7% -€345.40 -99.9% -0.4% -1.0 pp €8.52K -100.6% 9.2% -2.0 pp
    -€629.81K +24,153.4% -€638.84K +5,331.4% 101.4% -3.5 pp -€1.33M +20,360.1% 210.9% -0.39 pp
    -€2.60K -∞% -€11.76K +328.8% 452.9% +4.5 pp -€6.49K -101.4% 250.1% +2.5 pp
    €0.00 -100.0% -€2.74K -78.8% N/A €455.70K -164.3% N/A
    -€425.53 +9.3% -€12.93K +2.0% 3,037.8% -2.2 pp -€708.43K -13,117.5% 166,482.9% +1.7K pp
    -€389.43 -∞% -€12.67K -2.8% 3,253.4% +33 pp €5.44K -99.7% -1,397.5% -14 pp
    €0.00 -100.0% -€13.04K +40.9% N/A €2.16M -332.1% N/A
    €32.66M +514,750.6% -€9.25K -38.1% -0.0% +2.4 pp -€930.92K +66.1% -2.9% +88 pp
    €6.34K -96.5% -€14.93K +2,202.8% -235.4% -2.4 pp -€560.57K -80.6% -8,837.6% -73 pp
    €183.17K -€648.45 -0.4% -€2.89M -1,578.4%

    Notifications